WallStreetZenWallStreetZen

NYSEMKT: UAMY
United States Antimony Corp Stock

$0.25+0.01 (+4.17%)
Updated Apr 18, 2024
UAMY Price
$0.25
Fair Value Price
N/A
Market Cap
$26.59M
52 Week Low
$0.17
52 Week High
$0.48
P/E
-4.12x
P/B
1.04x
P/S
3.08x
PEG
N/A
Dividend Yield
N/A
Revenue
$8.69M
Earnings
-$6.35M
Gross Margin
-38.5%
Operating Margin
-73.03%
Profit Margin
-73.1%
Debt to Equity
0.1
Operating Cash Flow
-$5M
Beta
0.57
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

UAMY Overview

United States Antimony Corporation produces and sells antimony, silver, gold, and zeolite products in the United States and Canada. The company's Antimony division offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper. Its antimony oxide is also used as a color fastener in paints; as a catalyst for the production of polyester resins for fibers and films; as a catalyst for the production of polyethelene pthalate in plastic bottles; as a phosphorescent agent in fluorescent light bulbs; and as an opacifier for porcelains. In addition, this division offers sodium antimonite for use as a fining agent for glass in cathode ray tubes, and as a flame retardant; antimony metal for use in bearings, storage batteries, and ordnance; and precious metals. The company's Zeolite division provides zeolite deposits for soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, and animal nutrition applications. Its zeolite products also have applications in catalysts, petroleum refining, concrete, solar energy and heat exchange, desiccants, pellet binding, horse and kitty litter, and floor cleaners, as well as carriers for insecticides, pesticides, and herbicides. United States Antimony Corporation was founded in 1968 and is headquartered in Thompson Falls, Montana.

Zen Score

Industry Average (21)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how UAMY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UAMY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
UAMY is good value based on its book value relative to its share price (1.04x), compared to the US Other Industrial Metals & Mining industry average (2.19x)
P/B vs Industry Valuation
UAMY is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more UAMY due diligence checks available for Premium users.

Be the first to know about important UAMY news, forecast changes, insider trades & much more!

Valuation

UAMY price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.12x
Industry
13.53x
Market
41.33x

UAMY price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.04x
Industry
2.19x
UAMY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UAMY's financial health

Profit margin

Revenue
$1.7M
Net Income
-$3.6M
Profit Margin
-213.9%
UAMY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
UAMY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$28.1M
Liabilities
$2.6M
Debt to equity
0.1
UAMY's short-term assets ($14.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UAMY's short-term assets ($14.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UAMY's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
UAMY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$932.1k
Investing
$178.0k
Financing
-$213.5k
UAMY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

UAMY vs Mining Stocks

TickerMarket Cap1d %P/EP/B
UAMY$26.59M+1.23%-4.12x1.04x
WWR$25.61M-1.96%-3.00x0.18x
ELBM$23.45M+3.70%-14.00x0.18x
BYU$23.15M-2.50%-2.44x0.06x
LITM$17.94M-4.76%-1.87x1.00x

United States Antimony Stock FAQ

What is United States Antimony's quote symbol?

(NYSEMKT: UAMY) United States Antimony trades on the NYSEMKT under the ticker symbol UAMY. United States Antimony stock quotes can also be displayed as NYSEMKT: UAMY.

If you're new to stock investing, here's how to buy United States Antimony stock.

What is the 52 week high and low for United States Antimony (NYSEMKT: UAMY)?

(NYSEMKT: UAMY) United States Antimony's 52-week high was $0.48, and its 52-week low was $0.17. It is currently -48.54% from its 52-week high and 42.77% from its 52-week low.

How much is United States Antimony stock worth today?

(NYSEMKT: UAMY) United States Antimony currently has 107,647,317 outstanding shares. With United States Antimony stock trading at $0.25 per share, the total value of United States Antimony stock (market capitalization) is $26.59M.

United States Antimony stock was originally listed at a price of $0.85 in Feb 24, 2000. If you had invested in United States Antimony stock at $0.85, your return over the last 24 years would have been -70.94%, for an annualized return of -5.02% (not including any dividends or dividend reinvestments).

How much is United States Antimony's stock price per share?

(NYSEMKT: UAMY) United States Antimony stock price per share is $0.25 today (as of Apr 18, 2024).

What is United States Antimony's Market Cap?

(NYSEMKT: UAMY) United States Antimony's market cap is $26.59M, as of Apr 19, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

United States Antimony's market cap is calculated by multiplying UAMY's current stock price of $0.25 by UAMY's total outstanding shares of 107,647,317.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.